Want to track IRD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Opus Genetics Inc. (IRD) Statistics
Valuation metrics
Market Cap 358.34M
Enterprise value 444.82M
Trailing P/E (ttm) -4.76
Forward P/E -
PEG ratio 0.11
Price/Sales (ttm) 50.6
Price/Book (mrq) -44.41
Enterprise Value/Revenue 45.13
Enterprise Value/EBITDA -4.24
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.65M
Average volume (90 days) 1.47M
Price summary
52-Week low 1.35
52-Week high 7.07
Beta -
50-Day moving average 4.12
200-Day moving average 4.62
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 6 Nov 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -10.92%
Operating margin -5.13%
Operational effectiveness
Return on assets -1.16%
Return on equity 11.48%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.1
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.93
Total debt (mrq) -
Total Debt/Equity (mrq) -2.69
Current ratio (mrq) 12.19%
Book value per share (mrq) -0.14
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
